Emily Meichun Ko (Emily R Ko)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 5

Top Topics

Endometrial Cancer

Oxide Nanoparticles

Genome Wide Association

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Jo Bodurtha Smith, Maya H Sharma, Kristina Powell, Meredith Doherty, Stefanie N Hinkle, Emily Meichun Ko
Financial toxicity in gynecologic oncology: a multi-practice survey. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Katherine Hicks-Courant, Emily Meichun Ko, Koji Matsuo, Alexander Melamed, Dimitrios Nasioudis, Jose Alejandro Rauh-Hain, Shitanshu Uppal, Jason D Wright, Pedro T Ramirez
Secondary databases in gynecologic cancer research. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Anna Jo Bodurtha Smith, Maya H Sharma, Kristina Powell, Meredith Doherty, Stefanie N Hinkle, Emily Meichun Ko
Financial toxicity in gynecologic oncology: a multi-practice survey. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (6) (2024)
Katherine Hicks-Courant, Genevieve P Kanter, Marilyn M Schapira, Colleen M Brensinger, Qing Liu, Emily Meichun Ko
Intensity of end-of-life care for gynecologic cancer patients by primary oncologist specialty. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 32 (6) (2022)
Liuyang Wang, Emily Meichun Ko, James J Gilchrist, Kelly J Pittman, Anna Rautanen, Matti Pirinen, J Will Thompson, Laura G Dubois, Raymond J Langley, Sarah L Jaslow, Raul E Salinas, D Clayburn Rouse, M Arthur Moseley, Salim Mwarumba, Patricia Njuguna, Neema Mturi, null null, null null, Thomas N Williams, J Anthony G Scott, Adrian V S Hill, Christopher W Woods, Geoffrey S Ginsburg, Ephraim L Tsalik, Dennis C Ko
Human genetic and metabolite variation reveals that methylthioadenosine is a prognostic biomarker and an inflammatory regulator in sepsis. Science advances 3 (3) (2017)